Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Penicillin v + metronidazole is a combination of two antibiotics used primarily in the treatment of severe dental and oral infections, particularly those with both aerobic and anaerobic bacterial involvement. Penicillin V (phenoxymethylpenicillin) is a narrow-spectrum beta-lactam antibiotic that inhibits bacterial cell wall synthesis, mainly targeting Gram-positive organisms. Metronidazole is a nitroimidazole antibiotic effective against anaerobic bacteria and certain protozoa; it works by damaging microbial DNA. The combination is often prescribed for acute dento-alveolar infections (dental abscesses) when broader coverage for both aerobic and anaerobic pathogens is required or when infection severity warrants dual therapy[7][9][3]. This regimen may be considered as an alternative to amoxicillin plus metronidazole, especially where use of narrower spectrum agents like penicillin V is preferred[3]. Both drugs are well-established, approved antibiotics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on penicillin v + metronidazole.